Jesse I. Treu, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 71,578 shares at $6.62 ($474K) on 2013-04-15, disclosed to the SEC on 2013-04-17.
Scheduled sale ($474k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| OBLN | BUY | 2018-08-27 | $6.0M | — | Filing → |
| VCYT | SELL | 2018-08-02 | $10.8M | — | Filing → |
| VCYT | SELL | 2017-05-18 | $18K | — | Filing → |